Bioblast Consulting is a global bioanalytical and biomarker consulting firm supporting pharmaceutical and biotechnology companies from early discovery through clinical development and submission.

With over 24 years of hands-on industry experience, we specialize in method development, qualification, GLP validation, and clinical sample analysis across oligonucleotides, biotherapeutics, antibody–drug conjugates (ADCs), vaccines, and in-vitro diagnostics (IVD).

We combine scientific rigor with regulatory insight to design solutions that meet FDA, EMA, PMDA, and WHO standards ensuring data that are fit-for-purpose, defensible, and globally auditable.